Erratum: Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-β1-mediated growth suppression in adult T-cell leukemia/lymphoma (Oncogene (2010) 29 (4157-4169) (DOI:10.1038/onc.2010.172));Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-Β1-mediated growth suppression in adult T-cell leukemia/lymphoma

Oncogene

Volumn 29, Issue 29, 2010, Pages 4157-4169

  Nakahata, S ^a   Yamazaki, S ^b   Nakauchi, H ^b   Morishita, K ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

ATLL; Smad7; ZEB1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; P21 ACTIVATED KINASE; PROTEIN P300; PROTEIN ZEB1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; T CELL LEUKEMIA; TRANSCRIPTION INITIATION;

MURINAE;

EID: 77954952693     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.158     Document Type: Erratum

References (31)

1. Arnulf B, Villemain A, Nicot C, Mordelet E, Charneau P, Kersual J et al. (2002). Human T-cell lymphotropic virus oncoprotein Tax represses TGF-beta 1 signaling in human T cells via c-Jun activation: a potential mechanism of HTLV-I leukemogenesis. Blood 100: 4129-4138.
2. Bai S, Shi X, Yang X, Cao X. (2000). Smad6 as a transcriptional corepressor. J Biol Chem 275: 8267-8270.
3. Blobe GC, Schiemann WP, Lodish HF. (2000). Role of transforming growth factor b in human disease. N Engl J Med 342: 1350-1358.
4. Derynck R, Akhurst RJ, Balmain A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129.
5. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T et al. (2001). Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276: 12477-12480.
6. Gillis S, Smith KA. (1977). Long term culture of tumour-specific cytotoxic T cells. Nature 268: 154-156.
7. Hata A, Lagna G, Massague J, Hemmati-Brivanlou A. (1998). Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12: 186-197.
8. Hidaka T, Nakahata S, Hatakeyama K, Hamasaki M, Yamashita K, Kohno T et al. (2008). Down-regulation of TCF8 is involved in the leukemogenesis of adult-T cell leukemia/lymphoma. Blood 112: 383-393.
9. Inge TH, McCoy KM, Susskind BM, Barrett SK, Zhao G, Bear HD. (1992). Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytes. J Immunol 148: 3847-3856.
10. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH et al. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 6: 1365-1375.
11. Kim SJ, Kehrl JH, Burton J, Tendler CL, Jeang KT, Danielpour D et al. (1990). Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia. J Exp Med 172: 121-129.
12. Kingsley DM. (1994). The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8: 133-146.
13. Lin X, Duan X, Liang YY, Su Y, Wrighton KH, Long J et al. (2006). PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell 125: 915-928.
14. Lin X, Liang YY, Sun B, Liang M, Shi Y, Brunicardi FC et al. (2003). Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription. Mol Cell Biol 23: 9081-9093.
15. Miyoshi I, Kubonishi I, Yoshimoto S, Akagi T, Ohtsuki Y, Shiraishi Y et al. (1981). Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294: 770-771.
16. Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J et al. (2000). A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96: 3209-3214.
17. Mori N, Morishita M, Tsukazaki T, Giam CZ, Kumatori A, Tanaka Y et al. (2001). Human T-cell leukemia virus type I oncoprotein Tax represses Smad-dependent transforming growth factor beta signaling through interaction with CREB-binding protein/p300. Blood 97: 2137-2144.
18. Okada M, Maeda M, Tagaya Y, Taniguchi Y, Teshigawara K, Yoshiki T et al. (1985). TCGF (IL 2)-receptor induction Factor (S). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-1(+) T cell lines. J Immunol 135: 3995-4003.
19. Postigo AA. (2003). Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J 22: 2443-2452.
20. Schneider U, Schwenk HU, Bornkamm G. (1977). Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer 19: 621-626.
21. Shi Y, Massague J. (2003). Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700.
22. Seoane J, Le HV, Shen L, Anderson SA, Massague J. (2004). Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223.
23. Souchelnytskyi S, Nakayama T, Nakao A, Moren A, Heldin CH, Christian JL et al. (1998). Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. J Biol Chem 273: 25364-25370.
24. Suzuki C, Murakami G, Fukuchi M, Shimanuki T, Shikauchi Y, Imamura T et al. (2002). Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J Biol Chem 277: 39919-39925.
25. Tsukasaki K, Krebs J, Nagai K, Tomonaga M, Koeffler HP, Bartram CR et al. (2001). Comparative genomic hybridization analysis in adult T-cell leukemia/lymphoma: correlation with clinical course. Blood 97: 3875-3881.
26. van Grunsven LA, Schellens A, Huylebroeck D, Verschueren K. (2001). SIP1 (Smad interacting protein 1) and deltaEF1 (delta-crystallin enhancer binding factor) are structurally similar trans-criptional repressors. J Bone Joint Surg Am 83-A: Suppl 1 (Part 1): S40-S47.
27. Vermeer MH, van Doorn R, Dijkman R, Mao X, Whittaker S, van Voorst Vader PC et al. (2008). Novel and highly recurrent chromosomal alterations in Sezary syndrome. Cancer Res 68: 2689-2698.
28. Yamada Y, Ohmoto Y, Hata T, Yamamura M, Murata K, Tsukasaki K et al. (1996). Features of the cytokines secreted by adult T cell leukemia (ATL) cells. Leuk Lymphoma 21: 443-447.
29. Yasunaga J, Matsuoka M. (2003). Leukemogenesis of adult T-cell leukemia. Int J Hematol 78: 312-320.
30. Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M. (2004). Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103: 2753-2760.
31. Zhang S, Fei T, Zhang L, Zhang R, Chen F, Ning Y et al. (2007). Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation. Mol Cell Biol 27: 4488-4499.